Explain How Seebri and Utibron Stack Up Against Other Inhalers for COPD

Two new bronchodilators, Seebri Neohaler (SEE-bree) and Utibron Neohaler (YOO-tee-bron), will jostle for a place in the COPD market.

They both contain the long-acting anticholinergic, glycopyrrolate...and Utibron combines it with the long-acting beta-agonist, indacaterol.

Think of Seebri as similar to Spiriva (tiotropium), Tudorza (aclidinium), or Incruse (umeclidinium)...and Utibron as similar to Anoro (umeclidinium/vilanterol) or Stiolto (tiotropium/olodaterol).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote